Vasa Therapeutics is a privately held biopharmaceutical company based in Encinitas, California, focused on developing therapies for vascular diseases. The company specializes in the discovery and development of treatments for conditions such as heart failure, peripheral artery disease, and sarcopenia. Vasa Therapeutics utilizes an in-house drug discovery testing funnel to identify promising small molecule and peptide therapeutics, aiming to provide healthcare professionals with effective options for managing these significant health issues.
Ambulero, Inc is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.